Trial Profile
Phase I-II clinical trial of irinotecan hydrochloride (CPT-11) for refractory pediatric solid tumors.
Status:
Completed
Phase of Trial:
Phase I/II
Latest Information Update: 12 May 2016
Price :
$35
*
At a glance
- Drugs Irinotecan (Primary)
- Indications Solid tumours
- Focus Adverse reactions; Therapeutic Use
- 14 Jan 2010 New trial record